I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 4 studies | 31% ± 9% | |
| GABAergic neuron | 3 studies | 35% ± 10% | |
| glutamatergic neuron | 3 studies | 35% ± 12% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 4 studies | 31% ± 9% | |
| GABAergic neuron | 3 studies | 35% ± 10% | |
| glutamatergic neuron | 3 studies | 35% ± 12% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 1927.09 | 653 / 653 | 98% | 6.91 | 591 / 605 |
| brain | 100% | 1253.63 | 2634 / 2642 | 98% | 9.38 | 689 / 705 |
| adrenal gland | 99% | 1102.34 | 256 / 258 | 92% | 5.24 | 211 / 230 |
| ovary | 100% | 2199.26 | 180 / 180 | 90% | 5.51 | 385 / 430 |
| prostate | 100% | 1911.68 | 244 / 245 | 89% | 4.49 | 448 / 502 |
| pancreas | 100% | 756.01 | 327 / 328 | 88% | 3.89 | 156 / 178 |
| kidney | 99% | 884.49 | 88 / 89 | 86% | 5.14 | 774 / 901 |
| breast | 90% | 732.13 | 411 / 459 | 57% | 2.67 | 640 / 1118 |
| lung | 89% | 522.28 | 517 / 578 | 55% | 2.42 | 632 / 1155 |
| uterus | 100% | 1054.21 | 170 / 170 | 36% | 2.13 | 167 / 459 |
| bladder | 90% | 719.67 | 19 / 21 | 46% | 2.45 | 231 / 504 |
| stomach | 97% | 520.14 | 348 / 359 | 30% | 1.53 | 87 / 286 |
| intestine | 95% | 526.66 | 916 / 966 | 25% | 1.20 | 130 / 527 |
| liver | 86% | 382.04 | 195 / 226 | 25% | 0.73 | 101 / 406 |
| esophagus | 77% | 322.50 | 1116 / 1445 | 31% | 1.81 | 57 / 183 |
| skin | 56% | 244.77 | 1022 / 1809 | 44% | 2.28 | 210 / 472 |
| spleen | 98% | 472.09 | 235 / 241 | 0% | 0 | 0 / 0 |
| adipose | 62% | 305.47 | 746 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 56% | 2.11 | 45 / 80 |
| heart | 56% | 185.65 | 479 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 47% | 152.13 | 623 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.32 | 6 / 29 |
| peripheral blood | 17% | 156.63 | 154 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.20 | 4 / 45 |
| muscle | 4% | 11.65 | 34 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF334 |
| Protein name | Zinc finger protein 334 |
| Synonyms | hCG_40020 DKFZp572F2170 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | A0A0B4J1Y0 ENST00000692313.1 ENST00000625284.2 M0R3E1 ENST00000596323.1 Q5XKG8 ENST00000457685.6 Q8N3P8 ENST00000347606.8 ENST00000593880.1 A0A087X1P4 Q9HCZ1 ENST00000615481.4 |
